Will nanobiosensors change therapeutic drug monitoring? The case of methotrexate

Nanomedicine (Lond). 2015 Mar;10(4):521-4. doi: 10.2217/nnm.15.3.
No abstract available

Keywords: SPR; cancer treatment; medical laboratory; methotrexate; nanobiosensors; regulatory clearance; surface plasmon resonance; therapeutic drug monitoring.

Publication types

  • Editorial

MeSH terms

  • Antimetabolites, Antineoplastic / blood*
  • Drug Monitoring / methods*
  • Humans
  • Methotrexate / blood*
  • Nanotechnology
  • Neoplasms / drug therapy*
  • Surface Plasmon Resonance / methods*

Substances

  • Antimetabolites, Antineoplastic
  • Methotrexate